Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/108894) titled 'Skin Safety test of Baypure Exfoliating AHA BHA PHA Serum' on April 21.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Baypure Lifestyle Pvt Ltd
Intervention:
Intervention1: Finn chamber: Each patch contains 0.04ml (40 microliter) of 1.Exfoliating AHA BHA PHA Serum, Route of Administration: Topical Frequency: Once Duration:24hrs
Control Intervention1: Finn chamber: 2.Negative control(0.9% NaCl), 3.Positive Control- (1% SLS)
Recruitment S...